Cargando…

Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway

PURPOSE: Dysfunction of endothelial cells plays a key role in the pathogenesis of diabetic atherosclerosis. High glucose (HG) has been found as a key factor in the progression of diabetic complications, including atherosclerosis. PI3K/Akt/eNOS signaling pathway has been shown to involve in HG-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Fengxia, Yang, Yiying, Wei, Shanyin, Huang, Xiaojing, Peng, Zhijian, Ke, Xiao, Zeng, Zhicong, Song, Yinzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027865/
https://www.ncbi.nlm.nih.gov/pubmed/32103904
http://dx.doi.org/10.2147/DDDT.S242521
_version_ 1783498922259382272
author Lin, Fengxia
Yang, Yiying
Wei, Shanyin
Huang, Xiaojing
Peng, Zhijian
Ke, Xiao
Zeng, Zhicong
Song, Yinzhi
author_facet Lin, Fengxia
Yang, Yiying
Wei, Shanyin
Huang, Xiaojing
Peng, Zhijian
Ke, Xiao
Zeng, Zhicong
Song, Yinzhi
author_sort Lin, Fengxia
collection PubMed
description PURPOSE: Dysfunction of endothelial cells plays a key role in the pathogenesis of diabetic atherosclerosis. High glucose (HG) has been found as a key factor in the progression of diabetic complications, including atherosclerosis. PI3K/Akt/eNOS signaling pathway has been shown to involve in HG-induced vascular injuries. Hydrogen sulfide (H(2)S) has been found to exhibit protective effects on HG-induced vascular injuries. Moreover, H(2)S activates PI3K/Akt/eNOS pathway in endothelial cells. Thus, the present study aimed to determine if H(2)S exerts protective effects against HG-induced injuries of human umbilical vein endothelial cells (HUVECs) via activating PI3K/Akt/eNOS signaling. MATERIALS AND METHODS: The endothelial protective effects of H(2)S were evaluated and compared to the controlled groups. Cell viability, cell migration and tube formation were determined by in vitro functional assays; protein levels were evaluated by Western blot assay and ELISA; cell apoptosis was determined by Hoechst 33258 nuclear staining; Reactive oxygen species (ROS) production was evaluated by the ROS detection kit. RESULTS: HG treatment significantly inhibited PI3K/Akt/eNOS signaling in HUVECs, which was partially reversed by the H2S treatment. HG treatment inhibited cell viability of HUVECs, which were markedly prevented by H(2)S or PI3K agonist Y-P 740. HG treatment also induced HUVEC cell apoptosis by increasing the protein levels of cleaved caspase 3, Bax and Bcl-2, which were significantly attenuated by H(2)S or 740 Y-P. ROS production and gp91(phox) protein level were increased by HG treatment in HUVECs and this effect can be blocked by the treatment with H(2)S or Y-P 740. Moreover, HG treatment increased the protein levels of pro-inflammatory cytokines, caspase-1 and phosphorylated JNK, which was significantly attenuated by H(2)S or Y-P 740. Importantly, the cytoprotective effect of H(2)S against HG-induced injury was inhibited by LY294002 (an inhibitor of PI3K/Akt/eNOS signaling pathway). CONCLUSION: The present study demonstrated that exogenous H(2)S protects endothelial cells against HG-induced injuries by activating PI3K/Akt/eNOS pathway. Based on the above findings, we proposed that reduced endogenous H(2)S levels and the subsequent PI3K/Akt/eNOS signaling impairment may be the important pathophysiological mechanism underlying hyperglycemia-induced vascular injuries.
format Online
Article
Text
id pubmed-7027865
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70278652020-02-26 Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway Lin, Fengxia Yang, Yiying Wei, Shanyin Huang, Xiaojing Peng, Zhijian Ke, Xiao Zeng, Zhicong Song, Yinzhi Drug Des Devel Ther Original Research PURPOSE: Dysfunction of endothelial cells plays a key role in the pathogenesis of diabetic atherosclerosis. High glucose (HG) has been found as a key factor in the progression of diabetic complications, including atherosclerosis. PI3K/Akt/eNOS signaling pathway has been shown to involve in HG-induced vascular injuries. Hydrogen sulfide (H(2)S) has been found to exhibit protective effects on HG-induced vascular injuries. Moreover, H(2)S activates PI3K/Akt/eNOS pathway in endothelial cells. Thus, the present study aimed to determine if H(2)S exerts protective effects against HG-induced injuries of human umbilical vein endothelial cells (HUVECs) via activating PI3K/Akt/eNOS signaling. MATERIALS AND METHODS: The endothelial protective effects of H(2)S were evaluated and compared to the controlled groups. Cell viability, cell migration and tube formation were determined by in vitro functional assays; protein levels were evaluated by Western blot assay and ELISA; cell apoptosis was determined by Hoechst 33258 nuclear staining; Reactive oxygen species (ROS) production was evaluated by the ROS detection kit. RESULTS: HG treatment significantly inhibited PI3K/Akt/eNOS signaling in HUVECs, which was partially reversed by the H2S treatment. HG treatment inhibited cell viability of HUVECs, which were markedly prevented by H(2)S or PI3K agonist Y-P 740. HG treatment also induced HUVEC cell apoptosis by increasing the protein levels of cleaved caspase 3, Bax and Bcl-2, which were significantly attenuated by H(2)S or 740 Y-P. ROS production and gp91(phox) protein level were increased by HG treatment in HUVECs and this effect can be blocked by the treatment with H(2)S or Y-P 740. Moreover, HG treatment increased the protein levels of pro-inflammatory cytokines, caspase-1 and phosphorylated JNK, which was significantly attenuated by H(2)S or Y-P 740. Importantly, the cytoprotective effect of H(2)S against HG-induced injury was inhibited by LY294002 (an inhibitor of PI3K/Akt/eNOS signaling pathway). CONCLUSION: The present study demonstrated that exogenous H(2)S protects endothelial cells against HG-induced injuries by activating PI3K/Akt/eNOS pathway. Based on the above findings, we proposed that reduced endogenous H(2)S levels and the subsequent PI3K/Akt/eNOS signaling impairment may be the important pathophysiological mechanism underlying hyperglycemia-induced vascular injuries. Dove 2020-02-14 /pmc/articles/PMC7027865/ /pubmed/32103904 http://dx.doi.org/10.2147/DDDT.S242521 Text en © 2020 Lin et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lin, Fengxia
Yang, Yiying
Wei, Shanyin
Huang, Xiaojing
Peng, Zhijian
Ke, Xiao
Zeng, Zhicong
Song, Yinzhi
Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway
title Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway
title_full Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway
title_fullStr Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway
title_full_unstemmed Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway
title_short Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway
title_sort hydrogen sulfide protects against high glucose-induced human umbilical vein endothelial cell injury through activating pi3k/akt/enos pathway
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027865/
https://www.ncbi.nlm.nih.gov/pubmed/32103904
http://dx.doi.org/10.2147/DDDT.S242521
work_keys_str_mv AT linfengxia hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT yangyiying hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT weishanyin hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT huangxiaojing hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT pengzhijian hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT kexiao hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT zengzhicong hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway
AT songyinzhi hydrogensulfideprotectsagainsthighglucoseinducedhumanumbilicalveinendothelialcellinjurythroughactivatingpi3kaktenospathway